药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Tazarotene
Icosapent ethyl
The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Arsenic trioxide.
Tazarotene
Triflusal
The risk or severity of bleeding can be increased when Triflusal is combined with Arsenic trioxide.
Tazarotene
Cangrelor
The risk or severity of bleeding can be increased when Cangrelor is combined with Arsenic trioxide.
Tazarotene
Caplacizumab
The risk or severity of bleeding can be increased when Caplacizumab is combined with Arsenic trioxide.
Tazarotene
Andrographolide
The risk or severity of bleeding can be increased when Andrographolide is combined with Arsenic trioxide.
Tazarotene
Ibudilast
The risk or severity of bleeding can be increased when Ibudilast is combined with Arsenic trioxide.
Tazarotene
Beraprost
The risk or severity of bleeding can be increased when Beraprost is combined with Arsenic trioxide.
Tazarotene
Defibrotide
The risk or severity of bleeding can be increased when Defibrotide is combined with Arsenic trioxide.
Tazarotene
Resveratrol
The risk or severity of bleeding can be increased when Resveratrol is combined with Arsenic trioxide.
Tazarotene
Ridogrel
The risk or severity of bleeding can be increased when Ridogrel is combined with Arsenic trioxide.
Tazarotene
Moderna COVID-19 Vaccine
The therapeutic efficacy of Moderna COVID-19 Vaccine can be decreased when used in combination with Arsenic trioxide.
Tazarotene
Ebola Zaire vaccine (live, attenuated)
The therapeutic efficacy of Ebola Zaire vaccine (live, attenuated) can be decreased when used in combination with Arsenic trioxide.
Tazarotene
Modified vaccinia ankara
The therapeutic efficacy of Modified vaccinia ankara can be decreased when used in combination with Arsenic trioxide.
Tazarotene
Varicella Zoster Vaccine (Recombinant)
The therapeutic efficacy of Varicella Zoster Vaccine (Recombinant) can be decreased when used in combination with Arsenic trioxide.
Tazarotene
Yersinia pestis 195/p antigen (formaldehyde inactivated)
The therapeutic efficacy of Yersinia pestis 195/p antigen (formaldehyde inactivated) can be decreased when used in combination with Arsenic trioxide.
Tazarotene
Pertussis vaccine
The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Arsenic trioxide.
Tazarotene
Smallpox (Vaccinia) Vaccine, Live
The therapeutic efficacy of Smallpox (Vaccinia) Vaccine, Live can be decreased when used in combination with Arsenic trioxide.
Tazarotene
Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated)
The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Arsenic trioxide.
Tazarotene
Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated)
The therapeutic efficacy of Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated) can be decreased when used in combination with Arsenic trioxide.
Tazarotene
Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen
The therapeutic efficacy of Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen can be decreased when used in combination with Arsenic trioxide.